Table 1.
Overview of licensed meningococcal glycoconjugate vaccines.
| Serogroups | Carrier | Trade Name | Manufacturer |
|---|---|---|---|
| Internationally distributed meningococcal conjugate vaccines | |||
| Monovalent meningococcal conjugates | |||
| MenC | TT | NeisVac-C | Pfizer, former Baxter |
| MenC | CRM197 | Menjugate™ | GSK Vaccines, former Novartis |
| MenC | CRM197 | Meningitec | Nuron Biotech, former Pfizer |
| Combined meningococcal conjugates | |||
| MenACWY | DT | Menactra | Sanofi Pasteur |
| MenACWY | CRM197 | Menveo™ | GSK Vaccines, former Novartis |
| MenACWY | TT | Nimenrix | Pfizer, former GSK Vaccines |
| Combinations with non-meningococcal antigens | |||
| MenC/Hib | TT | Menitorix™ | GSK Vaccines |
| MenCY/Hib | TT | MenHibrix™ | GSK Vaccines |
| Regionally distributed meningococcal conjugate vaccines | |||
| MenA | TT | MenAfriVac | Serum Institute of India |
| MenAC | TT | MengNa Kang | Beijing Luzhu (subsidiary of ChongquingZhifei) |
| MenAC | TT | Nao Man Ning | Xiangrui (also known as Beijing Sanroad) |
| MenAC | TT | Wo Er Kang | Yunnan Walvax |
| MenAC | TT | MeningACon | BeijingZhifei Lvzhu Biopharmaceutical |
| MenAC | TT | N/A | Royal Wuxi |
Note.
CRM197, Cross Reacting Material 197; DT, diphtheria toxoid; Men, meningococcal serogroup; TT, tetanus toxoid